BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11853113)

  • 1. Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA.
    Kato K; Wada T; Kawakatsu S; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):201-3. PubMed ID: 11853113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Scheepmaker AJ; Horstink MW; Hoefnagels WH; Strijks FE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):32-5. PubMed ID: 12564296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
    Majic T; Mell T; Heinz A; Rapp MA
    Int Psychogeriatr; 2010 Jun; 22(4):678-9. PubMed ID: 20199702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of dementia with Lewy bodies].
    Lebert F; Le Rhun E
    Rev Neurol (Paris); 2006 Jan; 162(1):131-6. PubMed ID: 16446631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia with Lewy bodies: clinical features and treatment.
    Campbell S; Stephens S; Ballard C
    Drugs Aging; 2001; 18(6):397-407. PubMed ID: 11419914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.
    Manabe Y; Odawara T; Konishi O
    Psychogeriatrics; 2019 Jul; 19(4):345-354. PubMed ID: 30784148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with lewy bodies: therapeutic opportunities and pitfalls.
    Henriksen AL; St Dennis C; Setter SM; Tran JT
    Consult Pharm; 2006 Jul; 21(7):563-75. PubMed ID: 16934009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study.
    Murata M; Odawara T; Hasegawa K; Iiyama S; Nakamura M; Tagawa M; Kosaka K
    Neurology; 2018 Feb; 90(8):e664-e672. PubMed ID: 29367449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of levodopa in the management of dementia with Lewy bodies.
    Molloy S; McKeith IG; O'Brien JT; Burn DJ
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1200-3. PubMed ID: 16107351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa treatment and mood fluctuation in dementia with Lewy bodies: a case report.
    Fujishiro H; Kasanuki K; Nakamura S
    Psychogeriatrics; 2013 Dec; 13(4):250-3. PubMed ID: 24289466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of dementia with Lewy bodies.
    Fernandez HH; Wu CK; Ott BR
    Expert Opin Pharmacother; 2003 Nov; 4(11):2027-37. PubMed ID: 14596656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.
    Frank C
    Can Fam Physician; 2003 Oct; 49():1304-11. PubMed ID: 14594099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dementia with Lewy Bodies and its differentiation from Alzheimer's disease].
    Ransmayr G; Katzenschlager R; Dal-Bianco P; Wenning G; Bancher C; Jellinger K; Schmidt R; Poewe W
    Neuropsychiatr; 2007; 21(2):63-74. PubMed ID: 17640492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial.
    Culo S; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Pollock BG
    Alzheimer Dis Assoc Disord; 2010; 24(4):360-4. PubMed ID: 20625270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.
    Molloy SA; Rowan EN; O'Brien JT; McKeith IG; Wesnes K; Burn DJ
    J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1323-8. PubMed ID: 16952917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: some comments.
    McKeith I
    Int Psychogeriatr; 2010 Jun; 22(4):680. PubMed ID: 20170586
    [No Abstract]   [Full Text] [Related]  

  • 20. Levodopa response in dementia with lewy bodies: a 1-year follow-up study.
    Lucetti C; Logi C; Del Dotto P; Berti C; Ceravolo R; Baldacci F; Dolciotti C; Gambaccini G; Rossi G; Bonuccelli U
    Parkinsonism Relat Disord; 2010 Sep; 16(8):522-6. PubMed ID: 20615745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.